Post-op CXL pain linked to age

Article

Collagen cross-linking (CXL) can cause more intense postoperative pain in younger patients.

Collagen cross-linking (CXL) can cause more intense postoperative pain in younger patients, according to a paper published in Cornea.

Dr Vinícius Ghanem et al., Cornea Department, Sadalla Amin Ghanem Eye Hospital, Joinville, Brazil, conducted a prospective study on 178 consecutive eyes of 135 patients with progressive keratoconus who underwent CXL.

The need for analgaesia with 30 mg of codeine and subjective self-evaluation was used to assess postoperative pain. Subjective evaluation was completed using the Wong-Baker FACES Pain Rating Scale at the end of each postoperative (PO) day for five days. The correlation between postoperative pain/keratometric readings and central corneal thickness (CCT) was assessed preoperatively.

The results revealed the mean number of codeine pills administered was 0.94, 0.72 and 0.28 at iPO, PO1 and PO2, respectively. There was a significant link between age and pain at PO3 and PO4 and between age and number of codeine pills on iPO. However, there was no significant association between mean overall pain and preoperative apical keratometry and pachymetry readings.

After CXL, pain is especially intense in particular during the first three postoperative days, despite aggressive pain control regimens. However, on each consecutive day, pain and the need for analgaesia decreased significantly.

The abstract can be viewed here.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.